Back to GetFilings.com
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------
FORM 10-Q
(MARK ONE)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTER ENDED SEPTEMBER 30, 2003
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ________ TO _________
COMMISSION FILE NUMBER 1-10235
IDEX CORPORATION
(Exact Name of Registrant as Specified in its Charter)
DELAWARE 36-3555336
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
630 DUNDEE ROAD, NORTHBROOK, ILLINOIS 60062
(Address of principal executive offices) (Zip Code)
Registrant's telephone number: (847) 498-7070
Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as
defined in Rule 12b-2 of the Exchange Act).
Yes [X] No [ ]
Number of shares of common stock of IDEX Corporation outstanding as of
October 31, 2003: 32,905,401 (net of treasury shares).
================================================================================
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
IDEX CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS EXCEPT SHARE AND PER SHARE AMOUNTS)
SEPTEMBER 30, DECEMBER 31,
2003 2002
------------- ------------
ASSETS
Current assets
Cash and cash equivalents ................................................... $ 8,163 $ 6,952
Receivables - net ....................................................... 108,763 101,494
Inventories ............................................................. 104,820 105,580
Other current assets .................................................... 6,253 7,234
--------- ---------
Total current assets .................................................. 227,999 221,260
Property, plant and equipment - net ......................................... 143,143 148,246
Goodwill .................................................................... 551,154 530,663
Intangible assets - net ..................................................... 19,712 19,377
Other noncurrent assets ..................................................... 11,941 11,504
--------- ---------
Total assets .......................................................... $ 953,949 $ 931,050
========= =========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
Trade accounts payable .................................................. $ 57,520 $ 61,153
Dividends payable ....................................................... 4,605 4,548
Accrued expenses ........................................................ 52,735 42,631
--------- ---------
Total current liabilities ............................................. 114,860 108,332
Long-term debt .............................................................. 188,707 241,051
Other noncurrent liabilities ................................................ 83,814 74,876
--------- ---------
Total liabilities ..................................................... 387,381 424,259
--------- ---------
Shareholders' equity
Common stock, par value $.01 per share
Shares issued and outstanding: 2003 - 32,982,188; 2002 - 32,536,166 ..... 330 325
Additional paid-in capital .............................................. 195,289 182,538
Retained earnings ....................................................... 364,046 331,635
Minimum pension liability adjustment .................................... (10,571) (10,571)
Accumulated translation adjustment ...................................... 23,384 9,240
Treasury stock, at cost: 2003 - 89,485; 2002 - 59,350 ................... (2,903) (1,946)
Unearned compensation on restricted stock ............................... (3,007) (4,430)
--------- ---------
Total shareholders' equity ............................................ 566,568 506,791
--------- ---------
Total liabilities and shareholders' equity ............................ $ 953,949 $ 931,050
========= =========
See Notes to Consolidated Financial Statements.
1
IDEX CORPORATION AND SUBSIDIARIES
STATEMENTS OF CONSOLIDATED OPERATIONS
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
THIRD QUARTER NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
----------------------- -----------------------
2003 2002 2003 2002
--------- --------- --------- ---------
Net sales ............................................. $ 197,314 $ 189,105 $ 599,959 $ 554,471
Cost of sales ......................................... 121,136 117,491 367,355 343,294
--------- --------- --------- ---------
Gross profit .......................................... 76,178 71,614 232,604 211,177
Selling, general and administrative expenses .......... 47,235 44,669 150,703 133,459
Restructuring charge .................................. - - - 107
--------- --------- --------- ---------
Operating income ...................................... 28,943 26,945 81,901 77,611
Other income - net .................................... 5 (398) 366 (61)
--------- --------- --------- ---------
Income before interest expense and income taxes ....... 28,948 26,547 82,267 77,550
Interest expense ...................................... 3,352 3,951 10,721 12,525
--------- --------- --------- ---------
Income before income taxes ............................ 25,596 22,596 71,546 65,025
Provision for income taxes ............................ 9,087 7,810 25,399 23,084
--------- --------- --------- ---------
Net income ............................................ $ 16,509 $ 14,786 $ 46,147 $ 41,941
========= ========= ========= =========
Basic earnings per common share ....................... $ .51 $ .46 $ 1.42 $ 1.33
========= ========= ========= =========
Diluted earnings per common share ..................... $ .49 $ .45 $ 1.39 $ 1.30
========= ========= ========= =========
Share data:
Basic weighted average common shares outstanding ...... 32,661 32,245 32,445 31,475
========= ========= ========= =========
Diluted weighted average common shares outstanding .... 33,640 32,883 33,166 32,352
========= ========= ========= =========
See Notes to Consolidated Financial Statements.
2
IDEX CORPORATION AND SUBSIDIARIES
STATEMENT OF CONSOLIDATED SHAREHOLDERS' EQUITY
(IN THOUSANDS EXCEPT SHARE AND PER SHARE AMOUNTS)
COMMON UNEARNED
STOCK & MINIMUM COMPENSATION
ADDITIONAL PENSION ACCUMULATED ON TOTAL
PAID-IN RETAINED LIABILITY TRANSLATION TREASURY RESTRICTED SHAREHOLDERS'
CAPITAL EARNINGS ADJUSTMENT ADJUSTMENT STOCK STOCK EQUITY
---------- -------- ---------- ----------- -------- ------------ ------------
Balance, December 31, 2002........... $182,863 $331,635 $(10,571) $ 9,240 $(1,946) $ (4,430) $506,791
Net income........................... 46,147 46,147
Other comprehensive income
Unrealized translation adjustment 14,144 14,144
------- --------
Other comprehensive income..... 14,144 14,144
-------- ------- --------
Comprehensive income........... 46,147 14,144 60,291
-------- ------- --------
Issuance of 446,022 shares of
common stock from exercise of
stock options and deferred
compensation plans.................. 12,756 12,756
Amortization of restricted stock..... 1,423 1,423
Restricted shares surrendered for
tax withholdings.................... (957) (957)
Cash dividends declared - $.42 per
common share outstanding............ (13,736) (13,736)
-------- -------- -------- ------- ------- -------- --------
Balance, September 30, 2003.......... $195,619 $364,046 $(10,571) $23,384 $(2,903) $ (3,007) $566,568
======== ======== ======== ======= ======= ======== ========
See Notes to Consolidated Financial Statements.
3
IDEX CORPORATION AND SUBSIDIARIES
STATEMENTS OF CONSOLIDATED CASH FLOWS
(IN THOUSANDS)
NINE MONTHS
ENDED SEPTEMBER 30,
------------------------
2003 2002
--------- ---------
Cash flows from operating activities
Net income ...................................................... $ 46,147 $ 41,941
Adjustments to reconcile to net cash provided by operations:
Depreciation and amortization ............................... 20,976 20,942
Amortization of intangibles ................................. 487 424
Amortization of unearned compensation ....................... 1,423 1,424
Amortization of debt issuance expenses ...................... 435 435
Deferred income taxes ....................................... 5,678 5,515
Changes in:
Receivables - net ........................................ (8,700) (9,889)
Inventories .............................................. (192) 3,135
Trade accounts payable ................................... 5,929 9,626
Accrued expenses ......................................... 9,958 4,007
Other - net ................................................. 8,139 5,981
--------- ---------
Net cash flows from operating activities ................... 90,280 83,541
Cash flows from investing activities
Additions to property, plant and equipment .................. (13,614) (13,114)
Acquisition of businesses ................................... (22,163) (69,536)
Other - net ................................................. 3,326 3,848
--------- ---------
Net cash flows from investing activities .................. (32,451) (78,802)
Cash flows from financing activities
Borrowings under credit facilities for acquisitions ......... 22,163 69,536
Net repayments under credit facilities ...................... (67,973) (111,841)
Repayments of other long-term debt .......................... (4,402) (645)
Proceeds from issuance of common stock ...................... - 50,920
Dividends paid .............................................. (13,679) (13,177)
Proceeds from stock option exercises ........................ 10,853 5,665
Other - net ................................................. (3,580) (4,081)
--------- ---------
Net cash flows from financing activities .................. (56,618) (3,623)
--------- ---------
Net increase in cash ............................................ 1,211 1,116
Cash and cash equivalents at beginning of year .................. 6,952 4,972
--------- ---------
Cash and cash equivalents at end of period ...................... $ 8,163 $ 6,088
========= =========
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for:
Interest ................................................... $ 12,908 $ 15,960
Income taxes ............................................... 9,409 17,596
Significant non-cash activities:
Debt assumed upon acquisition of businesses ................ - 1,886
See Notes to Consolidated Financial Statements.
4
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
1. BUSINESS SEGMENTS
Information on IDEX's business segments is presented below, based on the
nature of products and services offered. IDEX evaluates performance based on
several factors, of which operating income is the primary financial measure.
Intersegment sales are accounted for at fair value as if the sales were to third
parties.
THIRD QUARTER NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
------------------------ ------------------------
2003 2002 2003 2002
--------- --------- --------- ---------
Net sales
Pump Products:
External customers .................... $ 114,161 $ 113,015 $ 336,881 $ 323,793
Intersegment sales .................... 745 770 2,166 2,171
--------- --------- --------- ---------
Total group sales ................... 114,906 113,785 339,047 325,964
--------- --------- --------- ---------
Dispensing Equipment:
External customers .................... 36,791 32,710 123,556 104,758
Intersegment sales .................... - 1 1 1
--------- --------- --------- ---------
Total group sales ................... 36,791 32,711 123,557 104,759
--------- --------- --------- ---------
Other Engineered Products:
External customers .................... 46,362 43,380 139,522 125,920
Intersegment sales .................... 2 - 4 1
--------- --------- --------- ---------
Total group sales ................... 46,364 43,380 139,526 125,921
--------- --------- --------- ---------
Intersegment elimination ................ (747) (771) (2,171) (2,173)
--------- --------- --------- ---------
Total net sales ..................... $ 197,314 $ 189,105 $ 599,959 $ 554,471
========= ========= ========= =========
Operating income
Pump Products ......................... $ 18,649 $ 20,165 $ 50,436 $ 55,044
Dispensing Equipment .................. 5,878 4,006 20,587 15,762
Other Engineered Products ............. 8,660 7,050 24,581 19,301
Corporate office and other ............ (4,244) (4,276) (13,703) (12,496)
--------- --------- --------- ---------
Total operating income .............. $ 28,943 $ 26,945 $ 81,901 $ 77,611
========= ========= ========= =========
A restructuring charge of $107 (net of reversal amount of $1,221) in 2002
is included within Corporate office and other and was not assigned to the
individual group segments. Had the Company allocated the 2002 restructuring
charge, the charge would have been assigned to the groups as follows: Pump
Products (income of $736), Dispensing Equipment (expense of $121) and Other
Engineered Products (expense of $722).
2. ACQUISITIONS
On September 5, 2003, the Company acquired Classic Engineering, Inc. based
in Jacksonville, Florida. Classic, with annual sales of approximately $4
million, is a supplier of fully integrated pump and metering systems to chemical
companies and municipal water treatment facilities. It engineers, designs and
manufactures a line of standard and custom chemical-feed systems for the water,
wastewater, chemical OEM, pulp and paper, cement and general industrial markets.
This acquisition operates as part of Pulsafeeder.
On June 2, 2003, IDEX acquired Sponsler Co., Inc., based in Westminster,
South Carolina. Sponsler, with annual sales of approximately $6 million, is a
manufacturer of a line of precision turbine flowmeters to meet all flow
applications, including low-flow and situations where viscosity, corrosive
media, extreme temperature or hazardous materials are factors. It operates as
part of Liquid Controls.
IDEX acquired the above businesses for an aggregate purchase price of
$14.2 million, with financing provided by borrowings under the Company's credit
facilities. The Company does not consider either of these acquisitions,
individually or combined, to be material to its financial position, liquidity or
results of operations.
5
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
3. RESTRUCTURING CHARGE
IDEX took actions in 2001 and 2002 to downsize operations to lower its
cost structure. These steps were necessary to appropriately size the Company's
production capacity and administrative support levels to match the lower levels
of demand for a broad range of products. A rollforward of the remaining
restructuring accrual related to the restructuring plans from January 1, 2003 to
September 30, 2003 is included below:
EMPLOYEE IDLE FACILITY
TERMINATION COSTS
COSTS AND OTHER TOTAL
----------- ------------- ------
Balance January 1, 2003 ........... $ 394 $ 86 $ 480
Payments .......................... (16) (37) (53)
----- ----- -----
Balance September 30, 2003 ........ $ 378 $ 49 $ 427
===== ===== =====
4. EARNINGS PER COMMON SHARE
Earnings per common share (EPS) are computed by dividing net income by the
weighted average number of shares of common stock (basic) plus common stock
equivalents outstanding (diluted) during the period. Common stock equivalents
consist of stock options, which have been included in the calculation of
weighted average shares outstanding using the treasury stock method, unvested
restricted shares, and shares issuable in connection with certain deferred
compensation agreements (DCUs). Basic weighted average shares reconciles to
diluted weighted average shares as follows:
THIRD QUARTER NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
------------------- -------------------
2003 2002 2003 2002
------- ------- ------- -------
Basic weighted average common shares outstanding .......................... 32,661 32,245 32,445 31,475
Dilutive effect of stock options, unvested restricted shares,
and DCUs .................................................................. 979 638 721 877
------ ------ ------ ------
Diluted weighted average common shares outstanding ........................ 33,640 32,883 33,166 32,352
====== ====== ====== ======
5. INVENTORIES
The components of inventories as of September 30, 2003 and December 31,
2002 were:
SEPTEMBER 30, DECEMBER 31,
2003 2002
------------- ------------
Raw materials ..................... $ 39,008 $ 41,985
Work-in-process ................... 14,139 11,960
Finished goods .................... 51,673 51,635
-------- --------
Total .................... $104,820 $105,580
======== ========
Those inventories which were carried on a LIFO basis amounted to $91,544
and $91,743 at September 30, 2003 and December 31, 2002, respectively. The
impact on earnings of using the LIFO method is not material.
6
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (CONTINUED)
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
6. COMMON AND PREFERRED STOCK
The Company had five million shares of preferred stock authorized but
unissued at September 30, 2003 and December 31, 2002.
7. STOCK OPTIONS
The Company has stock option plans for outside directors, executives and
certain key employees. These options are accounted for using the intrinsic value
method and, accordingly, no compensation cost has been recognized. Had
compensation cost been determined using the fair value method, the Company's pro
forma net income and earnings per share would have been as follows:
THIRD QUARTER NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
--------------------------- --------------------------
2003 2002 2003 2002
----------- ----------- ----------- -----------
Net income
As reported .......... $ 16,509 $ 14,786 $ 46,147 $ 41,941
=========== =========== =========== ===========
Pro forma ............ $ 15,316 $ 13,643 $ 42,565 $ 38,738
=========== =========== =========== ===========
Basic EPS
As reported .......... $ .51 $ .46 $ 1.42 $ 1.33
=========== =========== =========== ===========
Pro forma ............ $ .47 $ .42 $ 1.31 $ 1.23
=========== =========== =========== ===========
Diluted EPS
As reported .......... $ .49 $ .45 $ 1.39 $ 1.30
=========== =========== =========== ===========
Pro forma ............ $ .46 $ .41 $ 1.28 $ 1.20
=========== =========== =========== ===========
8. LEGAL PROCEEDINGS
IDEX is a party to various legal proceedings arising in the ordinary
course of business, none of which is expected to have a material adverse effect
on its business, financial condition or results of operations.
7
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
HISTORICAL OVERVIEW AND OUTLOOK
IDEX Corporation sells a broad range of pump products, dispensing
equipment and other engineered products to a diverse customer base in the United
States and other countries around the world. Accordingly, our businesses are
affected by levels of industrial activity and economic conditions in the U.S.
and in other countries where our products are sold, and by the relationship of
the U.S. dollar to other currencies. Among the factors that influence the demand
for our products are interest rates, levels of capacity utilization and capital
spending in certain industries and overall industrial activity.
We have a history of achieving above-average operating margins. Our
operating margins have exceeded the average for the companies that comprise the
Value Line Corporate Index (VLCI) every year since 1988. IDEX views the VLCI
operating performance statistics as a proxy for an average industrial company.
Our operating margins are influenced by, among other things, utilization of
facilities as sales volumes change and inclusion of newly acquired businesses.
The operating margins of newly acquired businesses typically have been lower
than the average of our base businesses and, prior to 2002, those margins were
further reduced by amortization of goodwill and trademark assets. In accordance
with new accounting rules, we discontinued amortizing intangible assets with
indefinite lives as of January 1, 2002. Instead, these intangible assets are
reviewed periodically for impairment.
For the three and nine month periods ended September 30, 2003, we reported
higher orders, sales, operating income, net income and diluted earnings per
share as compared with the same periods of last year.
Although the third quarter tends to be weaker than the second quarter due
to some business seasonality and slower activity in Europe during the summer
holidays, we were pleased with our financial performance. Orders and sales were
up versus a year ago and we recorded our fifth consecutive quarter of
year-over-year earnings improvement. We had our fourth consecutive quarter of
year-over-year organic growth in our businesses, driven by new product
introductions in all three segments, as well as our continued focus on
operational excellence. During the quarter, IDEX generated record cash flow from
operations, acquired Classic Engineering to expand our presence in a strategic
market, established a manufacturing operation in China, and continued to invest
in new products and new markets.
The following forward-looking statements are qualified by the cautionary
statement under the Private Securities Litigation Reform Act set forth below. As
anticipated, we had a decrease in sales sequentially as the second quarter tends
to be the strongest of the year. The fourth quarter also tends to be seasonally
lower than the second quarter and, in recent years, has been lower than the
third quarter. Due to the short-cycle nature of our business, our financial
performance depends on the current pace of incoming orders, and we have very
limited visibility of future business conditions. However, we believe IDEX is
well positioned for earnings improvement as the economy strengthens. This is
based on our lower cost structure resulting from restructuring actions; our
operational excellence initiatives of Kaizen and Lean Manufacturing, Six Sigma,
Global Sourcing and eBusiness; and using our strong cash flow to cut debt and
interest expense. In addition, we continue to pursue acquisitions to drive the
Company's longer term profitable growth.
CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT
The "Historical Overview and Outlook" and the "Liquidity and Capital
Resources" sections of this management's discussion and analysis of our
operations contain forward-looking statements within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act
of 1934, as amended. These statements may relate to, among other things, capital
expenditures, cost reductions, cash flow, and operating improvements and are
indicated by words or phrases such as "anticipate," "estimate," "plans,"
"expects," "projects," "should," "will," "management believes," "the Company
believes," "we believe," "the Company intends" and similar words or phrases.
These statements are subject to inherent uncertainties and risks that could
cause actual results to differ materially from those anticipated at the date of
this filing. The risks and uncertainties include, but are not limited to, the
following: economic and political consequences resulting from terrorist attacks
and wars; levels of industrial activity and economic conditions in the U.S. and
other countries around the world, pricing pressures and other competitive
factors, and levels of capital spending in certain industries - all of which
could have a material impact on our order rates and results, particularly in
light of the low levels of order backlogs we typically maintain; our ability to
make acquisitions and to integrate and operate acquired businesses on a
profitable basis; the
8
relationship of the U.S. dollar to other currencies and its impact on pricing
and cost competitiveness; political and economic conditions in foreign countries
in which we operate; interest rates; capacity utilization and the effect this
has on costs; labor markets; market conditions and material costs; and
developments with respect to contingencies, such as litigation and environmental
matters. The forward-looking statements included here are only made as of the
date of this report, and we undertake no obligation to publicly update them to
reflect subsequent events or circumstances. Investors are cautioned not to rely
unduly on forward-looking statements when evaluating the information presented
here.
RESULTS OF OPERATIONS
For purposes of this discussion and analysis section, reference is made to
the table on the following page and the Company's Statements of Consolidated
Operations included in the Financial Statements section. IDEX consists of three
reporting groups: Pump Products, Dispensing Equipment and Other Engineered
Products.
PERFORMANCE IN THE THREE MONTHS ENDED SEPTEMBER 30, 2003 COMPARED TO THE SAME
PERIOD OF 2002
For the three months ended September 30, 2003, orders, sales and profits
were higher than the comparable third quarter of last year. New orders for the
latest three months totaled $193.7 million, 3% higher than the same period last
year. Excluding the impact of foreign currency, the sales reduction associated
with an immaterial product line sold earlier this year, and the Halox (April
2002), Rheodyne (July 2002), Wrightech (October 2002), Sponsler (June 2003) and
Classic (September 2003) acquisitions, orders were 2% lower than the third
quarter of 2002.
Sales in the third quarter were $197.3 million, a 4% improvement from last
year's third quarter as foreign currency translation provided a 4% increase and
base business shipments were up slightly. Acquisitions net of the product line
sold did not affect the year-over-year comparison. Domestic sales in the quarter
were 1% lower, while international sales - net of foreign currency translation -
rose 3% as all three groups experienced global growth. Sales to international
customers, including the impact of currency translation, were 44% of the total,
up from 43% last year.
For the quarter, the Pump Products Group contributed 58% of sales and 56%
of operating income, the Dispensing Equipment Group accounted for 19% of sales
and 18% of operating income, and the Other Engineered Products Group represented
23% of sales and 26% of operating income.
Pump Products Group sales of $114.9 million for the three months ended
September 30, 2003, were $1.1 million, or 1%, higher than the prior year mainly
due to the acquisition of Rheodyne in July 2002. Compared with the third quarter
last year, acquisitions accounted for a 3% sales improvement and foreign
currency translation added 2%, while base business shipments were down 4% as
demand in the chemical processing and industrial end-markets remained soft. In
the third quarter of 2003, domestic sales increased slightly while international
sales increased by 2%. Excluding acquisitions and foreign currency translation,
U.S. sales volume decreased 4% while international sales decreased 5%. Sales to
customers outside the U.S., including the impact of currency translation, was
38% of total group sales in both periods.
Dispensing Equipment Group sales of $36.8 million increased $4.1 million,
or 12%, in the third quarter of 2003 compared with last year's third quarter.
This increase was attributed to favorable foreign currency translation of 11%
and a 1% increase in base business volume as demand for color formulation
equipment in Europe strengthened. In the third quarter of 2003, domestic sales
decreased by 14% and international sales increased by 21%. Excluding the
favorable foreign currency translation effect, international sales volume
increased by 2%. Sales to customers outside the U.S., including the impact of
currency translation, were 63% of total group sales in the 2003 quarter,
compared with 54% in 2002.
Other Engineered Products Group sales of $46.4 million increased by $3.0
million, or 7%, in the third quarter of 2003 compared with 2002. This increase
reflects an 11% increase in base business volume. Foreign currency translation
added another 3%, while the impact of the sale of the product line reduced sales
by 7%. In the third quarter of 2003, domestic sales increased by 6%, while
international sales increased by 8%. Excluding foreign currency translation and
the impact of the sale of the product line, international sales increased 19%
from the comparable period of last year. Sales to customers outside the U.S.,
including the impact of currency translation, were 42% of total group sales in
2003, unchanged from 2002.
9
IDEX CORPORATION AND SUBSIDIARIES
COMPANY AND BUSINESS GROUP FINANCIAL INFORMATION
(IN THOUSANDS)
THIRD QUARTER NINE MONTHS
ENDED SEPTEMBER 30, (1) ENDED SEPTEMBER 30, (1)
---------------------- ----------------------
2003 2002 2003 2002
-------- -------- -------- --------
Pump Products Group
Net sales ............................ $114,906 $113,785 $339,047 $325,964
Operating income (2) ................. 18,649 20,165 50,436 55,044
Operating margin ..................... 16.2% 17.7% 14.9% 16.9%
Depreciation and amortization ........ $ 4,139 $ 4,254 $ 12,630 $ 12,902
Capital expenditures ................. 3,796 1,595 9,083 5,865
Dispensing Equipment Group
Net sales ............................ $ 36,791 $ 32,711 $123,557 $104,759
Operating income (2) ................. 5,878 4,006 20,587 15,762
Operating margin ..................... 16.0% 12.2% 16.7% 15.0%
Depreciation and amortization ........ $ 1,390 $ 1,502 $ 4,459 $ 4,517
Capital expenditures ................. 582 1,098 1,655 2,875
Other Engineered Products Group
Net sales ............................ $ 46,364 $ 43,380 $139,526 $125,921
Operating income (2) ................. 8,660 7,050 24,581 19,301
Operating margin ..................... 18.7% 16.3% 17.6% 15.3%
Depreciation and amortization ........ $ 1,389 $ 1,118 $ 3,989 $ 3,705
Capital expenditures ................. 723 1,336 2,658 4,166
Company
Net sales ............................ $197,314 $189,105 $599,959 $554,471
Operating income (2) ................. 28,943 26,945 81,901 77,611
Operating margin ..................... 14.7% 14.2% 13.7% 14.0%
Depreciation and amortization (3) .... $ 7,520 $ 7,442 $ 22,887 $ 22,790
Capital expenditures ................. 5,207 4,069 13,614 13,114
(1) Includes acquisition of Halox Technologies, Inc. (April 2002), Rheodyne,
L.P. (July 2002), Wrightech Corporation (October 2002), Sponsler Co., Inc.
(June 2003) and Classic Engineering, Inc. (September 2003) in the Pump
Products Group from the dates of acquisition.
(2) Group operating income excludes unallocated corporate operating expenses
in both years and the restructuring activity discussed below in 2002. IDEX
took actions in 2002 to downsize operations to lower its cost structure.
In June 2002, IDEX reversed $1.2 million of certain accrued restructuring
expenses initially recorded in 2001. The reversal primarily resulted from
higher than anticipated proceeds on asset sales. The restructuring charge
of $107 (net of the reversal amount of $1.2 million) was included with
corporate and other in 2002 and was not assigned to the individual group
segments. Had the company allocated the 2002 restructuring charge, it
would have been assigned to the groups as follows: Pump Products (income
of $736), Dispensing Equipment (expense of $121) and Other Engineered
Products (expense of $722).
(3) Excludes amortization of debt issuance expenses.
10
Gross profit of $76.2 million in the third quarter of 2003 increased by
$4.6 million, or 6%, from 2002. Gross profit as a percent of sales was 38.6% in
2003 and increased from 37.9% in 2002. The improved gross margins primarily
reflected increased sales volume, lower material costs from our Global Sourcing
activities, and savings from Lean, Kaizen and Six Sigma initiatives.
Operating income increased by $2.0 million, or 7%, to $28.9 million in
2003 from $26.9 million in 2002, primarily reflecting the higher gross margins
discussed above partially offset by increased selling, general and
administrative expenses (SG&A). Third quarter operating margins were 14.7% of
sales, .5 of a percentage point higher than at this time last year. The
improvement from last year resulted from the .7 percentage point increase in
gross margins discussed above, which was slightly offset by an increase in total
Company SG&A. In the Pump Products Group, operating income of $18.6 million and
operating margins of 16.2% in 2003 were down from the $20.2 million and 17.7%
recorded in 2002 principally due to lower base business shipments. Operating
income for the Dispensing Equipment Group of $5.9 million and operating margins
of 16.0% in 2003 were up from the $4.0 million and 12.2% in 2002 due to
increased volume and production efficiencies. Operating income in the Other
Engineered Products Group of $8.7 million and operating margins of 18.7% in 2003
increased from $7.1 million and 16.3% achieved in 2002 and primarily reflected
increased sales volume and a more favorable mix of product shipments.
SG&A increased to $47.2 million in 2003 from $44.7 million in 2002, and as
a percent of sales was 23.9%, slightly up from 23.6% in 2002. The increase in
SG&A expenses reflected the cumulative impact of acquisitions made in 2003 and
2002, deliberate reinvestment in the businesses to drive organic growth, and
cost increases including pension, insurance, audit and legal expenses.
Interest expense decreased to $3.4 million in the third quarter of 2003
from $4.0 million in 2002. This reduction was principally attributable to
significantly lower debt levels this year due to debt paydowns from operating
cash flow and a lower interest rate environment.
The provision for income taxes increased to $9.1 million in 2003 from $7.8
million in 2002. The effective tax rate increased to 35.5% in 2003 from 34.6% in
2002.
Net income for the current quarter was $16.5 million, 12% higher than the
$14.8 million earned in the third quarter of 2002. Diluted earnings per share in
the third quarter of 2003 of $.49 increased $.04 compared with the third quarter
of 2002.
PERFORMANCE IN THE NINE MONTHS ENDED SEPTEMBER 30, 2003 COMPARED TO THE SAME
PERIOD OF 2002
Orders, sales and profits were higher for the first nine months of 2003
compared with the same period last year. New orders for the first nine months of
2003 totaled $604.0 million, 8% higher than last year. Excluding the impact of
foreign currency translation, the immaterial product line sold, and acquisitions
made since the beginning of 2002, orders were 1% higher than the comparable
period of 2002.
Sales in the first nine months increased 8% to $600.0 million from $554.5
million a year ago. Acquisitions less the sales impact of the product line sold
accounted for a 1% improvement, foreign currency translation added 5% and base
business rose 2%. Domestic sales were 1% lower, while international sales - net
of foreign currency translation - were 11% higher. Sales to international
customers, including the impact of currency translation, were 45% of the total,
up from 42% last year.
For the first nine months of 2003, the Pump Products Group contributed 56%
of sales and 53% of operating income, the Dispensing Equipment Group accounted
for 21% of both sales and operating income, and the Other Engineered Products
Group represented 23% of sales and 26% of operating income.
Pump Products Group sales of $339.0 million increased $13.1 million, or
4%, for the nine months ended September 30, 2003 compared with 2002.
Acquisitions accounted for a 5% sales improvement and foreign currency
translation added 2% but this was offset by a 3% decline in base business sales.
In the first nine months of 2003, domestic sales decreased by 1% while
international sales increased by 13%. Excluding acquisitions and foreign
currency translation, U.S. sales volume decreased by 6% while international
sales increased 2%. Sales to customers outside the U.S., including the impact of
currency translation, increased to 39% of total group sales in the 2003 period
from 36% in 2002.
11
Dispensing Equipment Group sales of $123.6 million increased $18.8
million, or 18%, in the first nine months of 2003 compared with the same period
last year. This increase was attributed to favorable foreign currency
translation of 14% and a 4% increase in base business volume as demand in
European markets has remained strong for color formulation equipment. Domestic
sales decreased by 7% and international sales increased by 33%. Excluding the
favorable foreign currency translation effect, international sales volume
increased by 8%. Sales to customers outside the U.S., including the impact of
currency translation, were 64% of total group sales in the 2003 period, compared
with 55% in 2002.
Other Engineered Products Group sales of $139.5 million increased by $13.6
million, or 11%, in the first nine months of 2003 compared with 2002.This
reflected a 13% increase in base business volume, particularly for fire and
rescue products, and a 4% improvement from foreign currency translation, which
was partially offset by a 6% decline related to the product line sale. In the
first nine months of 2003, domestic sales increased by 7%, while international
sales increased by 16%. Excluding foreign currency and the impact of the sale of
the product line, international sales increased 23% from the comparable period
of last year. Sales to customers outside the U.S., including the impact of
currency translation, were 43% of total group sales in 2003, up from 42% in
2002.
Gross profit of $232.6 million in the first nine months of 2003 increased
by $21.4 million, or 10%, from 2002. Gross profit as a percent of sales was
38.8% in 2003 and increased from 38.1% in 2002. The improved gross margins
primarily reflected increased sales volume, lower material costs from our Global
Sourcing activities, and savings from Lean, Kaizen and Six Sigma initiatives.
Operating income increased by $4.3 million, or 6%, to $81.9 million in
2003 from $77.6 million in 2002, primarily reflecting the higher gross margins
discussed above partially offset by increased SG&A expenses. Operating margins
for the first nine months of 2003 were 13.7% compared with 14.0% in the prior
year period. The margin decrease from last year was primarily due to an
unfavorable mix of sales (away from higher margin pump sales) and an increase in
SG&A, partially offset by the improvement in gross margins. In the Pump Products
Group, operating income of $50.4 million and operating margins of 14.9% in 2003
were down from the $55.0 million and 16.9% recorded in 2002. Operating income
for the Dispensing Equipment Group of $20.6 million and operating margins of
16.7% in 2003 were up from the $15.8 million and 15.0% in 2002. Operating income
in the Other Engineered Products Group of $24.6 million and operating margins of
17.6% in 2003 increased from $19.3 million and 15.3% achieved in 2002.
SG&A increased to $150.7 million in 2003 from $133.5 million in 2002, and
as a percent of sales was 25.1%, up from 24.1% in 2002. The increase in SG&A
expenses reflected the cumulative impact of acquisitions made in 2003 and 2002,
deliberate reinvestment in the businesses to drive organic growth, and cost
increases including pension, insurance, audit and legal expenses.
Interest expense decreased to $10.7 million in the first nine months of
2003 from $12.5 million in 2002. This reduction was principally attributable to
significantly lower debt levels this year due to debt paydowns from operating
cash flow and proceeds from the April 2002 issuance of common stock, as well as
a lower interest rate environment.
The provision for income taxes increased to $25.4 million in 2003 from
$23.1 million in 2002. The effective tax rate was 35.5% for both the 2003 and
2002 periods.
Net income for the first nine months of 2003 was $46.1 million, 10% higher
than the $41.9 million earned in the same period of 2002. Diluted earnings per
share in the first nine months of 2003 of $1.39 increased $.09 compared with the
same period last year.
LIQUIDITY AND CAPITAL RESOURCES
At September 30, 2003, working capital was $113.1 million and our current
ratio was 2.0 to 1. Cash flows from operating activities increased $6.7 million,
or 8%, to $90.3 million in 2003 mainly due to the improved operating results
discussed above.
Cash flow provided from operations was more than adequate to fund capital
expenditures of $13.6 million and $13.1 million in the first nine months of 2003
and 2002, respectively. Capital expenditures were generally for
12
machinery and equipment that improved productivity and tooling to support IDEX's
Global Sourcing initiatives, although a portion was for business system
technology and replacement of equipment and facilities. Management believes that
IDEX has ample capacity in its plant and equipment to meet expected needs for
future growth in the intermediate term.
In February 2003, an $8.0 million payment of deferred consideration was
made in respect of the Rheodyne acquisition, which was consummated in July 2002.
The Company also completed the acquisitions of Sponsler in June 2003 and Classic
Engineering in September 2003 for a cost of $10.4 million and $3.8 million,
respectively. These payments were financed under the Company's credit facility.
At September 30, 2003, the maximum amount available under our
multi-currency bank revolving credit facility (Credit Facility) was $300.0
million, of which $5.6 million was borrowed. The Credit Facility contains a
covenant that limits total debt outstanding to three times operating cash flow,
as defined in the agreement. Our total debt outstanding was $188.7 million at
September 30, 2003, and based on the covenant was limited to $410.1 million of
total debt outstanding. Interest is payable quarterly on the outstanding balance
at the agent bank's reference rate or at LIBOR plus an applicable margin and a
utilization fee if the total borrowings exceed certain levels. The applicable
margin is based on the credit rating of our 6.875% senior notes due February 15,
2008, and can range from 25 basis points to 100 basis points. The utilization
fee can range from zero to 25 basis points. On March 27, 2003, Standard & Poor's
upgraded its corporate credit and senior unsecured debt ratings on IDEX to BBB
from BBB-. As a result of this change, at September 30, 2003, the applicable
margin was 57.5 basis points and the utilization fee was zero. We also pay an
annual fee of 17.5 basis points on the total Credit Facility.
In December 2001, we, and certain of our subsidiaries, entered into a
one-year agreement with a financial institution, under which we collateralized
certain receivables for borrowings (Receivables Facility). This agreement was
renewed in December 2002 for another year. The Receivables Facility provides for
borrowings of up to $50.0 million, depending upon the level of eligible
receivables. At September 30, 2003, $20.0 million was borrowed and included in
long-term debt at an interest rate of approximately 2.5% per annum.
We also have a $30.0 million demand line of credit (Short-Term Facility),
which expires May 24, 2004. Borrowings under the Short-Term Facility are at
LIBOR plus the applicable margin in effect under the Credit Facility. At
September 30, 2003, $6.0 million was borrowed and included in long-term debt at
an interest rate of approximately 1.7% per annum.
We believe the Company will generate sufficient cash flow from operations
for the next twelve months and in the long term to meet its operating
requirements, interest on all borrowings, any authorized share repurchases,
restructuring expenses, planned capital expenditures, and annual dividend
payments to holders of common stock. Since we began operations in January 1988
and through September 30, 2003, we have borrowed approximately $906.0 million
under our various credit agreements to complete 24 acquisitions. During the same
period we generated, principally from operations, cash flow of $882.0 million to
reduce indebtedness. In the event that suitable businesses are available for
acquisition upon terms acceptable to the Board of Directors, we may obtain all
or a portion of the financing for the acquisitions through the incurrence of
additional long-term debt.
Our contractual obligations and commercial commitments include rental
payments under operating leases, payments under capital leases, and other
long-term obligations arising in the ordinary course of business. We have no
off-balance sheet arrangements or material long-term purchase obligations. There
are no identifiable events or uncertainties, including the lowering of our
credit rating, that would accelerate payment or maturity of any of these
commitments or obligations.
CRITICAL ACCOUNTING ESTIMATES
We believe that the application of the following accounting policies,
which are important to our financial position and results of operations,
requires significant judgments and estimates on the part of management. For a
summary of all of our accounting policies, including the accounting policies
discussed below, see Note 1 of the Notes to the Consolidated Financial
Statements in our 2002 Annual Report on Form 10-K.
Noncurrent assets - The Company evaluates the recoverability of certain
noncurrent assets utilizing various estimation processes. In particular, the
recoverability of September 30, 2003 balances for goodwill and intangible assets
of $551.2 million and $19.7 million, respectively, are subject to estimation
processes, which depend on the
13
accuracy of underlying assumptions, including future operating results. The
Company evaluates the recoverability of each of these assets based on estimated
business values and estimated future cash flows (derived from estimated earnings
and cash flow multiples). The recoverability of these assets depends on the
reasonableness of these assumptions and how they compare with the eventual
operating performance of the specific businesses to which the assets are
attributed. To the extent actual business values or cash flows differ from those
estimated amounts, the recoverability of these noncurrent assets could be
affected.
Income taxes - Deferred taxes are recognized for the future tax effects of
temporary differences between financial and income tax reporting using tax rates
in effect for the years in which the differences are expected to reverse.
Federal income taxes are provided on that portion of the income of foreign
subsidiaries that is expected to be remitted to the United States and be
taxable. The management of the Company, along with third-party advisors,
periodically estimate the Company's probable tax obligations using historical
experience in tax jurisdictions and informed judgments.
Contingencies and litigation - We are currently involved in certain legal and
regulatory proceedings and, as required and where it is reasonably possible to
do so, have accrued our estimates of the probable costs for the resolution of
these matters. These estimates have been developed in consultation with outside
counsel and are based upon an analysis of potential results, assuming a
combination of litigation and settlement strategies. It is possible, however,
that future operating results for any particular quarterly or annual period
could be materially affected by changes in our assumptions or the effectiveness
of our strategies related to these proceedings.
Defined benefit retirement plans - The plan obligations and related assets of
defined benefit retirement plans are presented in Note 14 of the Notes to the
Consolidated Financial Statements in the 2002 Annual Report on Form 10-K. Plan
assets, which consist primarily of marketable equity and debt instruments, are
valued using market quotations. Plan obligations and the annual pension expense
are determined by consulting actuaries using a number of assumptions. Key
assumptions in measuring the plan obligations include the discount rate at which
the obligation could be effectively settled and the anticipated rate of future
salary increases. Key assumptions in the determination of the annual pension
expense include the discount rate, the rate of salary increases and the
estimated future return on plan assets. To the extent actual amounts differ from
these assumptions and estimated amounts, results could be adversely affected.
REGISTRATION STATEMENT FILINGS FOR COMMON STOCK OFFERINGS
In March 2002, we filed a registration statement on Form S-3 with the
Securities and Exchange Commission covering the secondary offering of 2,939,199
shares of common stock owned by IDEX Associates, L.P. In April 2002, that
registration statement was amended to also include the secondary offering of
560,801 shares of IDEX common stock owned by KKR Associates, L.P., and the
primary offering of 1,500,000 shares of IDEX common stock. Also in April 2002,
we announced the pricing of this public offering at $36 per common share.
Subsequently, the overallotment option was exercised by the underwriter for the
sale of an additional 750,000 secondary shares owned by KKR Associates, L.P.,
bringing the total offering to 5,750,000 shares. The $50.8 million of net
proceeds we received was used to repay debt under the Credit Facility. This
increased the amount available for borrowing under the facility, which we will
continue to use for general corporate purposes, including acquisitions.
In September 2002, we filed a registration statement on Form S-3 with the
Securities and Exchange Commission covering the secondary offering of 1,350,000
shares of IDEX common stock owned by KKR Associates, L.P. This offering,
completed in January 2003, did not increase the number of IDEX shares
outstanding, and the Company did not receive any proceeds from the offering.
The secondary shares covered by both of these registration statements had
been owned by KKR Associates, L.P. and IDEX Associates, L.P. since IDEX was
formed in January 1988.
14
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
The Company is subject to market risk associated with changes in interest
rates and foreign currency exchange rates. Interest rate exposure is limited to
the $188.7 million of total debt outstanding at September 30, 2003.
Approximately 20% of the debt is priced at interest rates that float with the
market. A 50 basis point movement in the interest rate on the floating rate debt
would result in an approximate $.2 million annualized increase or decrease in
interest expense and cash flows. The remaining debt is fixed rate debt. We will,
from time to time, enter into interest rate swaps on our debt when we believe
there is a financial advantage for doing so. A treasury risk management policy,
adopted by the Board of Directors, describes the procedures and controls over
derivative financial and commodity instruments, including interest rate swaps.
Under the policy, we do not use derivative financial or commodity instruments
for trading purposes, and the use of these instruments is subject to strict
approvals by senior officers. Typically, the use of derivative instruments is
limited to interest rate swaps on the Company's outstanding long-term debt.
Our foreign currency exchange rate risk is limited principally to the euro
and British pound. We manage our foreign exchange risk principally through
invoicing our customers in the same currency as the source of our products.
ITEM 4. CONTROLS AND PROCEDURES.
The Company maintains disclosure controls and procedures that are designed
to ensure that information required to be disclosed in the Company's Exchange
Act reports is recorded, processed, summarized and reported within the time
periods specified in the SEC's rules and forms, and that such information is
accumulated and communicated to the Company's management, including its Chief
Executive Officer and Chief Financial Officer, as appropriate, to allow timely
decisions regarding required disclosure. In designing and evaluating the
disclosure controls and procedures, management recognized that any controls and
procedures, no matter how well designed and operated, can provide only
reasonable assurance of achieving the desired control objectives, and management
is required to apply its judgment in evaluating the cost-benefit relationship of
possible controls and procedures.
As required by SEC Rule 13a-15(b), the Company carried out an evaluation,
under the supervision and with the participation of the Company's management,
including the Company's Chief Executive Officer and the Company's Chief
Financial Officer, of the effectiveness of the design and operation of the
Company's disclosure controls and procedures as of the end of the quarter
covered by this report. Based on the foregoing, the Company's Chief Executive
Officer and Chief Financial Officer concluded that the Company's disclosure
controls and procedures were effective at the reasonable assurance level.
There has been no change in the Company's internal controls over financial
reporting during the Company's most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the Company's internal
control over financial reporting.
15
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
IDEX and nine of its subsidiaries have been named as defendants in a
number of lawsuits claiming various asbestos-related personal injuries,
allegedly as a result of exposure to products manufactured with components that
contained asbestos. Such components were acquired from third party suppliers,
and were not manufactured by any of the subsidiaries. To date, all of the
Company's settlements and legal costs, except for costs of coordination,
administration, insurance investigation and a portion of defense costs, have
been covered in full by insurance. However, the Company cannot predict whether
and to what extent insurance will be available to continue to cover such
settlements and legal costs, or how insurers may respond to claims that are
tendered to them.
Claims have been filed in California, Connecticut, Georgia, Illinois,
Louisiana, Michigan, Mississippi, New Jersey, New York, Ohio, Pennsylvania,
Texas and Washington. A few claims have been settled for minimal amounts and
some have been dismissed without payment. None have been tried.
No provision has been made in the financial statements of the Company, and
IDEX does not currently believe the asbestos-related claims will have a material
adverse effect on the Company's business or financial position.
IDEX is also party to various other legal proceedings arising in the
ordinary course of business, none of which is expected to have a material
adverse effect on its business, financial condition or results of operations.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.
(a) Exhibits:
The exhibits listed in the accompanying "Exhibit Index" are filed
as part of this report.
(b) Reports on Form 8-K:
A report under Item 9 dated July 17, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
IDEX CORPORATION
November 10, 2003 /s/ WAYNE P. SAYATOVIC
--------------------------------
Wayne P. Sayatovic
Senior Vice President - Finance
and Chief Financial Officer
16
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
- ------- -----------
3.1 Restated Certificate of Incorporation of IDEX Corporation (formerly
HI, Inc.) (incorporated by reference to Exhibit No. 3.1 to the
Registration Statement on Form S-1 of IDEX, et al., Registration No.
33-21205, as filed on April 21, 1988)
3.1(a) Amendment to Restated Certificate of Incorporation of IDEX
Corporation (formerly HI, Inc.), (incorporated by reference to
Exhibit No. 3.1(a) to the Quarterly Report of IDEX on Form 10-Q for
the quarter ended March 31, 1996, Commission File No. 1-10235)
3.2 Amended and Restated By-Laws of IDEX Corporation (incorporated by
reference to Exhibit No. 3.2 to Post-Effective Amendment No. 2 to
the Registration Statement on Form S-1 of IDEX, et al., Registration
No. 33-21205, as filed on July 17, 1989)
3.2(a) Amended and Restated Article III, Section 13 of the Amended and
Restated By-Laws of IDEX Corporation (incorporated by reference to
Exhibit No. 3.2(a) to Post-Effective Amendment No. 3 to the
Registration Statement on Form S-1 of IDEX, et al., Registration No.
33-21205, as filed on February 12, 1990)
4.1 Restated Certificate of Incorporation and By-Laws of IDEX
Corporation (filed as Exhibits No. 3.1 through 3.2 (a))
4.2 Indenture, dated as of February 23, 1998, between IDEX Corporation,
and Norwest Bank Minnesota, National Association, as Trustee,
relating to the 6-7/8% Senior Notes of IDEX Corporation due February
15, 2008 (incorporated by reference to Exhibit No. 4.1 to the
Current Report of IDEX on Form 8-K dated February 23, 1998,
Commission File No. 1-10235)
4.3 Specimen Senior Note of IDEX Corporation (incorporated by reference
to Exhibit No. 4.1 to the Current Report of IDEX on Form 8-K dated
February 23, 1998, Commission File No. 1-10235)
4.4 Specimen Certificate of Common Stock of IDEX Corporation
(incorporated by reference to Exhibit No. 4.3 to the Registration
Statement on Form S-2 of IDEX, et al., Registration No. 33-42208, as
filed on September 16, 1991)
4.5 Credit Agreement, dated as of June 8, 2001, among IDEX Corporation,
Bank of America N.A. as Agent and Issuing Bank, and the Other
Financial Institutions Party Hereto (incorporated by reference to
Exhibit No. 4.5 to the Quarterly Report of IDEX on Form 10-Q for the
quarter ended June 30, 2001, Commission File No. 1-10235)
4.6 Credit Lyonnais Uncommitted Line of Credit, dated as of December 3,
2001 (incorporated by reference to Exhibit 4.6 to the Annual Report
of IDEX on Form 10-K for the year ended December 31, 2001,
Commission File No. 1-10235)
4.6(a) Amendment No. 2 dated as of May 24, 2003 to the Credit Lyonnais
Uncommitted Line of Credit Agreement dated December 3, 2001
(incorporated by reference to Exhibit 4.6 (a) to the Quarterly
Report of IDEX on Form 10-Q for the quarter ended June 30, 2003,
Commission File No. 1-10235)
4.7 Receivables Purchase Agreement dated as of December 20, 2001 among
IDEX Receivables Corporation, as Seller, IDEX Corporation, as
Servicer, Falcon Asset Securitization Corporation, the Several
Financial Institutions from Time to Time Party Hereto, and Bank One,
NA (Main Office Chicago), as Agent (incorporated by reference to
Exhibit 4.7 to the Annual Report of IDEX on Form 10-K for the year
ended December 31, 2001, Commission File No. 1-10235)
4.7(a) Amended and Restated Fee Letter dated as of December 18, 2002 of the
Receivables Purchase Agreement dated as of December 20, 2001
(incorporated by reference to Exhibit 4.7 (a) to the Annual Report
of IDEX on Form 10-K for the year ended December 31, 2002,
Commission File No. 1-10235)
10.1 Third Amended and Restated 1996 Stock Option Plan for Non-Officer
Key Employees of IDEX Corporation dated January 9, 2003
(incorporated by reference to Exhibit 4.1 to the Registration
Statement on Form S-8 of IDEX, Registration No. 333-104768, as filed
on April 25, 2003)
17
EXHIBIT INDEX (CON'T.)
EXHIBIT
NUMBER DESCRIPTION
- ------- -----------
10.2** Revised and Restated IDEX Management Incentive Compensation Plan for
key employees effective January 1, 2003
*31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)
or Rule 15d-14(a)
*31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)
or Rule 15d-14(a)
*32.1 Certification pursuant to Section 1350 of Chapter 63 of Title 18 of
the United States Code
*32.2 Certification pursuant to Section 1350 of Chapter 63 of Title 18 of
the United States Code
-----------
* Filed herewith
** Management contract or compensatory plan or agreement
18